A Pilot Randomized Controlled Trial of Omega-3 Fatty Acids for Autism Spectrum Disorder

We conducted a pilot randomized controlled trial to determine the feasibility and initial safety and efficacy of omega-3 fatty acids (1.3 g/day) for the treatment of hyperactivity in 27 children ages 3–8 with autism spectrum disorder (ASD). After 12 weeks, hyperactivity, as measured by the Aberrant...

Descripción completa

Detalles Bibliográficos
Autores principales: Bent, Stephen, Bertoglio, Kiah, Ashwood, Paul, Bostrom, Alan, Hendren, Robert L.
Formato: Texto
Lenguaje:English
Publicado: Springer US 2010
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076562/
https://www.ncbi.nlm.nih.gov/pubmed/20683766
http://dx.doi.org/10.1007/s10803-010-1078-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076562/
https://www.ncbi.nlm.nih.gov/pubmed/20683766
http://dx.doi.org/10.1007/s10803-010-1078-8

Ejemplares similares